Boston Scientific Corp. Stock Hits New 52-Week Low at $43.37

Boston Scientific Corp. has reached a significant milestone by touching a new 52-week low of USD 43.37 on June 29, 2026. This marks a notable decline in the stock's performance, with a one-year decrease of 43.84%, contrasting sharply with the S&P 500's gain of 20.53% during the same period. As a large-cap company in the retailing industry, Boston Scientific Corp. holds a market capitalization of USD 120,852 million. The stock currently has a price-to-earnings (P/E) ratio of 36.00, indicating its valuation relative to earnings. The company has a debt-to-equity ratio of 0.39, suggesting a moderate level of debt compared to its equity. Additionally, Boston Scientific Corp. has a return on equity of 13.88%, reflecting its efficiency in generating profits from shareholders' equity. Despite the recent price movement, the stock's performance metrics highlight its position within the retailing sector, as it navigates through current market conditions.